942400-60-4 Usage
Description
1-(2-bromo-5-chlorophenyl)methanamine is a chemical compound characterized by a benzene ring with a bromine and a chlorine substituent attached. It also features a methanamine group, which is a carbon atom bonded to three hydrogen atoms and a nitrogen atom. 1-(2-bromo-5-chlorophenyl)methanamine is known for its potential applications in various fields, including pharmaceuticals, agrochemicals, and organic chemistry.
Uses
Used in Pharmaceutical Synthesis:
1-(2-bromo-5-chlorophenyl)methanamine is used as an intermediate in the synthesis of pharmaceuticals for [application reason]. Its unique structure allows for the creation of various medicinal compounds that can target specific health conditions.
Used in Agrochemical Production:
In the agrochemical industry, 1-(2-bromo-5-chlorophenyl)methanamine is used as a building block for the development of new agrochemicals for [application reason]. Its properties contribute to the effectiveness of these products in agricultural applications.
Used in Organic Chemistry Research:
1-(2-bromo-5-chlorophenyl)methanamine is also utilized in the field of organic chemistry as a research compound for [application reason]. Its structure and reactivity make it a valuable tool for understanding and developing new chemical reactions and processes.
It is crucial to handle 1-(2-bromo-5-chlorophenyl)methanamine with care due to its potential health and environmental hazards if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 942400-60-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,2,4,0 and 0 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 942400-60:
(8*9)+(7*4)+(6*2)+(5*4)+(4*0)+(3*0)+(2*6)+(1*0)=144
144 % 10 = 4
So 942400-60-4 is a valid CAS Registry Number.
942400-60-4Relevant articles and documents
2-METHYL-QUINAZOLINES
-
Page/Page column 338-339; 393-394, (2018/10/19)
The present invention describes 2-methyl-quinazoline compounds of general formula (I), methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions. The 2-methyl substituted quinazoline compounds of general formula(I) effectively and selectively inhibit the Ras-Sos interaction without significantly targeting the EGFR receptor. They are therefore useful for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, such as cancer as a sole agent or in combination with other active ingredients.
Isoquinolin-3-Ylurea Derivatives
-
Paragraph 0720; 0844; 0845, (2013/04/24)
The invention relates to isoquinolin-3-ylurea derivatives of formula (I) wherein R1 represents (C1-C3)alkyl, (C1-C3)haloalkyl or cyclopropyl, R4 represents H and the substituents R2 and R3 and R5 have the meanings disclosed in the specification; and to the salts of such compounds. These compounds are useful for the prevention or the treatment of bacterial infections.
ANTIBACTERIAL ISOQUINOLIN-3-YLUREA DERIVATIVES
-
Page/Page column 115, (2011/10/13)
The invention relates to isoquinolin-3-ylurea derivatives of formula (I) wherein R1 represents (C1-C3)alkyl, (C1-C3)haloalkyl or cyclopropyl, R4 represents H and the substituents R2 and R3 and R5 have the meanings disclosed in the specification; and to the salts of such compounds. These compounds are useful for the prevention or the treatment of bacterial infections.
